JAK2 and Alzheimer disease: In this study, it was observed that the expression of OX40L was inhibited by JAK1/JAK2 inhibitor MMB, and it was demonstrated that MMB can exhibit a powerful therapeutic efficacy for AD through inhibiting the expression of OX40L and consequently adjusting the Th2 immune response.